Rod Breau

Tremendous thanks to @Uroweb for putting on session on EBM in urology moderated by @MariaJRibal @KariTikkinen and includes @GuyattGH who coined the term EBM #EAU26

A hospital policy of tranexamic acid to reduce (RBC) transfusion in major non-cardiac surgery: The TRACTION trial [Dec 9, 2025] Houston et al. #ASH25 LBA-5 meetings-api.hematology.org/api/abstract/v… #NCT04803747 #anemia #hemeonc no increase in #VTE

@BrettLHouston presenting the results of the TRACTION trial as a late-breaking at #ASH25. In 8300 pts undergoing major non cardiac surgery, a policy of tranexamic acid reduces RBC transfusion w/ no difference in VTE at 90 days @umanitoba @CancerCareMB @CIHR_IRSC @Research_MB

A pleasure to finally share our findings of a large RCT of radical cystectomy patients from 10 Canadian institutions. To our shock, TXA did not reduce transfusion. Thank you to the patients, collaborators, and the many research staff. @WesKassouf @mcisaac_d @CIHR_IRSC

In a multicenter randomized trial, tranexamic acid did not reduce blood transfusion during radical cystectomy. ja.ma/3XMBIMV

@tompowles1 @DrDabestani @kalasri3 @Uromigos Thanks Tom, you can also view this study as showing PET reduced burden on patients (I.e major surgery) without worsening survival. @kalasri3 #ESMO23

FDG-PET CT is widely used in NMIBC. @kalasri3 @uromigos investigator led study showed in a randomised trial it didn’t change practice or outcomes. I’m going to stop using PET in MIBC it delays and complicated things without clear benefit. #ESMO23

@WesKassouf @AmerUrological @SFreedlandMD @CanUrolAssoc @RSanchez_Salas @ChapinMD @UroOncMD Learning a lot from this trial for sure - congrats to authors and patients! Caveat is that these are high risk patients and no observation until mets arm. In lower risk PSA-recurrent, observation with delayed doublet or triplet Tx (if/when Mets detected) may still be “better”.

Nice study. Is it time to modify AUA #prostatecancer guidelines as currently the recommendation is not to give any hormonal therapies until metastasis?@AmerUrological @SFreedlandMD @CanUrolAssoc @RodBreau @RSanchez_Salas @ChapinMD @UroOncMD

Just published: Estimated glomerular filtration rate from the renal hypothermia trial: clinical implications by @LemireFrancis1 @RodBreau et al. bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…

#CUAOnDemand Network Meta-Analyses (NMA) in Practice Missed the live webinar? No worries, we have you covered 😀 you can access this session and also complete the quiz for your section 3 credits. Click here: cua.org/UROpedia #UROpediaCanada @RodBreau @WallisCJD

On June 23, at the CUA Mtg. in Montreal, Dr. Armen Aprikian announced the re-naming of the CUASF - KCRNC Kidney Cancer Cancer Research Grant as The Anil Kapoor Kidney Cancer Research Grant in memory of his leadership & support of kidney cancer research. #CUA23 @KidneyCancer_Ca

Hot off the press! Check out the latest CKCF Consensus Statement; "Adjuvant therapy for RCC: 2023." cuaj.ca/index.php/jour… @lalaniMD @lukelavallee @nbasappaCCI @RodBreau @BBhindi @SiTanguay @NeilReaumeMD @DrJeffreyGraham @Dominick_Bosse @ShaanDudani @DrDanielHeng

🥾⛺️JOIN US TONIGHT for #1! Clinical Evidence Bootcamp Series! ➡️SIGN up for 1, 2 or all 3! simply select your date & time: cua.org/upcoming-events @winsoncheung @WallisCJD @RodBreau @Astellas

Thank you to Ameeta and the team for looking at a prediction model to determine if a renal tumour is benign or malignant using #ckcisdata! #ckcis #AUA2023 #canadiandata #kidneycancer @RodBreau @SiTanguay @BBhindi @UroOncMD

Outstanding presentation by Dr. Landan MacDonald ⁦predicting salvage cystectomy post TMT ⁦@DalUrology⁩ #AUA2023

Dr Levitt presenting patient survey data used to inform our post prostatectomy Adj ADT trial. Partnering with patients for an acceptable design (1 yr ADT) with outcomes (avoiding radiation and recurrence) imp to patients @AUA2023 @CIHR_IRSC @ProstateCancerC @RSanchez_Salas

RIP Anil Kapoor ⁦@anilkapoormd⁩ giant in the field who contributed so much remembered #AUA2023 ⁦@CanUrolAssoc⁩

@VickersBiostats on Major trials in GU oncology that famously did not accrue; appeal to keep it real/simple in terms of inclusion criteria, consents…@RodBreau @ChapinMD @ChuckScalesMD @VikramNarayan #AUA2023

Great job @Raees__Cassim on discussing the Canadian experience for the outcomes of cT2 RCC via partial Nx! @RahulBansal_13 @RodBreau @nbasappaCCI @UroOncMD @SiTanguay @BBhindi #AUA2023 #Canadiandata #registry #kidneycancer #CKCis

High quality guidelines are so important. This is a great way to learn more about how to create and use clinical practice guidelines +/- new pair of cowboy boots

🔥📽️ Luke Lavallée @lukelavallee discusses: A survey of physician perception and practices regarding pharmacological thromboprophylaxis during chemotherapy for bladder cancer >>> To read 📖: cuaj.ca/index.php/jour…